Dr. Ravindranath chosen for Pediatric Hematologic Steering Committee overseeing trials
Tuesday, January 11, 2011
|
|
| Dr Yaddanapudi Ravindranath |
Yaddanapudi Ravindranath, M.B.B.S., senior member of the clinical leadership council at the Barbara Ann Karmanos Cancer Institute, as well as the Georgie Ginopolis chair for Pediatric Cancer and Hematology at the Children’s Hospital of Michigan, has been appointed a member of the National Cancer Institute’s Pediatric Steering Committee.
The committee – a Pediatric Hematology subcommittee -- is responsible for reviewing all pediatric clinical trials and biology studies in leukemia and lymphoma submitted to the NCI for funding. The group is part of several disease-specific steering committees formed in response to recommendations of the National Cancer Advisory Board Clinical Trials Working Group report.
The committees involve the broad oncology medical community to address the design and prioritization of phase III and selected phase II trials.
Dr. Ravindranath will serve on the committee at least two years.
"It is an honor to be asked to serve on this committee, whose work may have a significant impact on the direction of national clinical trials in childhood leukemia and lymphoma in the U.S.," said Dr. Ravindranath, who also serves as professor of Pediatrics at Wayne State University School of Medicine.